Evidence map›Paper›PMID 36807342›Full record

ArticleEuropean journal of human genetics : EJHG2023

KidneyNetwork: using kidney-derived gene expression data to predict and prioritize novel genes involved in kidney disease.

Floranne Boulogne, Laura R Claus, Henry Wiersma, Roy Oelen, Floor Schukking, Niek de Klein, Shuang Li, Harm-Jan Westra, Bert van der Zwaag, Franka van Reekum and 12 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Sporadic ADPKDKidney international reports · 2024
    Article
  7. Gene regulatory networks in disease and ageing.Nature reviews. Nephrology · 2024
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 3 countries.

Floranne Boulogne *Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-5893-1401
Laura R Claus *Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Henry Wiersma *Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Roy Oelen *Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Floor SchukkingDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Niek de KleinDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0003-4640-9904
Shuang LiDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Harm-Jan WestraDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-7038-567X
Bert van der ZwaagDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Franka van ReekumDepartment of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands.
Genomics England Research Consortium
Dana SierksMedical Department III - Endocrinology, Nephrology, Rheumatology Department of Internal Medicine, Division of Nephrology, University of Leipzig Medical Center, Leipzig, Germany.
Ria SchönauerMedical Department III - Endocrinology, Nephrology, Rheumatology Department of Internal Medicine, Division of Nephrology, University of Leipzig Medical Center, Leipzig, Germany.
Zhigui LiDepartment of Internal Medicine (Nephrology), Yale School of Medicine, New Haven, CT, USA.
Emilia K BijlsmaDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Willem Jan W BosDepartment of Internal Medicine, St Antonius Hospital, Nieuwegein, The Netherlands.ORCID 0000-0002-5062-2567
Jan HalbritterMedical Department III - Endocrinology, Nephrology, Rheumatology Department of Internal Medicine, Division of Nephrology, University of Leipzig Medical Center, Leipzig, Germany.
Nine V A M KnoersDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Whitney BesseDepartment of Internal Medicine (Nephrology), Yale School of Medicine, New Haven, CT, USA.
Patrick DeelenDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-5654-3966
Lude FrankeDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Albertien M van EerdeDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. A.vanEerde@umcutrecht.nl.ORCID 0000-0001-5953-5956
University Medical Center Groningen · NLUniversity Medical Center Utrecht · NLHumboldt-Universität zu Berlin · DELeiden University Medical Center · NLYale University · US

Funding

Yale Center for Mendelian DisordersU54HG006504 · NHGRI · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER, GUNEL, MURAT · 2012 to 2015
$11.0M
Molecular genetic bases of polycystic and tubulointerstitial kidney diseasesK08DK119642 · NIDDK · YALE UNIVERSITY · PI BESSE, WHITNEY ELISE · 2019 to 2023
$939k
High Performance Computing Instrumentation for the Yale Center for Genome AnalysiS10OD018521 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2015 to 2015
$890k
NCI NIH HHS HHSN261200800001ENHGRI NIH HHS U54 HG006504NHLBI NIH HHS HHSN268201000029CNIDDK NIH HHS K08 DK119642NIH HHS S10 OD018521
6 · The paper itself

Abstract

Genetic testing in patients with suspected hereditary kidney disease may not reveal the genetic cause for the disorder as potentially pathogenic variants can reside in genes that are not yet known to be involved in kidney disease. We have developed KidneyNetwork, that utilizes tissue-specific expression to inform candidate gene prioritization specifically for kidney diseases. KidneyNetwork is a novel method constructed by integrating a kidney RNA-sequencing co-expression network of 878 samples with a multi-tissue network of 31,499 samples. It uses expression patterns and established gene-phenotype associations to predict which genes could be related to what (disease) phenotypes in an unbiased manner. We applied KidneyNetwork to rare variants in exome sequencing data from 13 kidney disease patients without a genetic diagnosis to prioritize candidate genes. KidneyNetwork can accurately predict kidney-specific gene functions and (kidney disease) phenotypes for disease-associated genes. The intersection of prioritized genes with genes carrying rare variants in a patient with kidney and liver cysts identified ALG6 as plausible candidate gene. We strengthen this plausibility by identifying ALG6 variants in several cystic kidney and liver disease cases without alternative genetic explanation. We present KidneyNetwork, a publicly available kidney-specific co-expression network with optimized gene-phenotype predictions for kidney disease phenotypes. We designed an easy-to-use online interface that allows clinicians and researchers to use gene expression and co-regulation data and gene-phenotype connections to accelerate advances in hereditary kidney disease diagnosis and research. TRANSLATIONAL STATEMENT: Genetic testing in patients with suspected hereditary kidney disease may not reveal the genetic cause for the patient's disorder. Potentially pathogenic variants can reside in genes not yet known to be involved in kidney disease, making it difficult to interpret the relevance of these variants. This reveals a clear need for methods to predict the phenotypic consequences of genetic variation in an unbiased manner. Here we describe KidneyNetwork, a tool that utilizes tissue-specific expression to predict kidney-specific gene functions. Applying KidneyNetwork to a group of undiagnosed cases identified ALG6 as a candidate gene in cystic kidney and liver disease. In summary, KidneyNetwork can aid the interpretation of genetic variants and can therefore be of value in translational nephrogenetics and help improve the diagnostic yield in kidney disease patients.

Indexed as

Kidney DiseasesKidney Diseases, CysticLiver DiseasesGene ExpressionHumansKidneyPhenotype

Identifiers

PMID36807342
PMCPMC10620423
OpenAlexW4321377252

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.